Endotherapy Devices Market Poised to Hit $6.57 Billion by 2029 with Accelerating Growth Trends

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Endotherapy Devices Market Size Growth Forecast: What to Expect by 2025?
In recent times, the market size of endotherapy devices has been experiencing robust growth. The market is set to expand from $4.63 billion in 2024 to $4.87 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 5.2%. This historical growth can be linked to factors such as a surge in gastrointestinal diseases, an aging demographic, advancements in early detection, suitable compensation policies, worldwide economic growth, as well as strategic alliances and partnerships.

How Will the Endotherapy Devices Market Size Evolve and Grow by 2029?
The market size for endotherapy devices is anticipated to experience robust growth in the forthcoming years, reaching $6.57 billion by 2029 with a compound annual growth rate (CAGR) of 7.8%. The escalation during the forecast period can be credited to the progression in minimally invasive methods, the increasing prevalence of chronic illnesses, enhancement of healthcare infrastructure, heightened attention on early diagnosis, regulatory backing and standardization. Key trends in the forecast period comprise advancements in imaging technologies, the incorporation of artificial intelligence, technological progress, worldwide advancement of healthcare infrastructure, and a growing incidence of gastrointestinal disorders.

View the full report here:
https://www.thebusinessresearchcompany.com/report/endotherapy-devices-global-market-report

What Drivers Are Propelling the Growth of Endotherapy Devices Market Forward?
The growth of the endotherapy devices market is anticipated to be driven by an increase in the occurrence of gastrointestinal ailments. Diseases that affect the digestive tract, such as colorectal cancer, gastroesophageal reflux disease, ulcerative colitis (UC), inflammatory bowel disease (IBD), Crohn's disease (CD), among others, fall under the umbrella of these gastrointestinal disorders. Endotherapy devices, which are utilized to execute non-invasive or minimally invasive surgical procedures, aid in the treatment and diagnosis of issues like ulcers, bleeding, celiac disease, blockages, inflammation, and tumors in the gastrointestinal tract. They also assist in identifying the root cause of inexplicable symptoms like heartburn, abdominal pain, bleeding, nausea, vomiting, and discomfort. For example, data published by Cancer Australia in January 2024 revealed that Australia anticipated 2,576 new stomach cancer cases in 2023, comprising 1,647 males and 929 females. The risk of being diagnosed by the age of 85 is around 1 in 117 (0.85%), with males at 1 in 91 (1.1%) and females at 1 in 164 (0.61%). Thus, the increasing prevalence of gastrointestinal diseases is essentially fueling the expansion of the endotherapy devices market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10157&type=smp

What Are the Key Trends Driving Endotherapy Devices Market Growth?
Leading firms in the endotherapy devices sector are innovating with advanced solutions such as red dichromatic imaging (RDI), a method that augments the visualization of blood vessels and hemorrhage spots during endoscopic processes. By utilizing two separate light wavelengths, RDI in endotherapy tools amplifies the visibility of segments and blood vessels, thereby enhancing diagnostic accuracy. To demonstrate, Olympus Corporation, a medical technology company from Japan, introduced the EVIS X1 endoscopy system in October 2023, a cutting-edge endoscopy platform. This system integrates sophisticated imaging technologies and artificial intelligence to boost visualization and diagnosis proficiency. The EVIS X1, with its advanced imaging systems, enhances diagnostic capabilities. It includes texture and color enhancement imaging (TXI) to increase the visibility of lesions and polyps by enhancing their color and texture. The use of red dichromatic imaging (RDI) targets deeper blood vessels and bleeding points, while brightness adjustment imaging with maintenance of contrast (BAI-MAC) evens out brightness levels throughout the image.

What Are the Key Segments in the Endotherapy Devices Market?
The endotherapy devices market covered in this report is segmented -

1) By Product: Gastrointestinal Devices and Accessories, Endoscopic Retrograde Cholangio Pancreatography Devices And Accessories, Other Endotherapy Devices
2) By Application: Bronchoscopy, Arthroscopy, Laparoscopy, Urology Endoscopy, Neuro-Endoscopy, Gastrointestinal Endoscopy, Other Applications
3) By End-Use: Hospital, Ambulatory Surgical Centers, Other End-Users

Subsegments:
1) By Gastrointestinal Devices And Accessories: Endoscopic Mucosal Resection (EMR) Devices, Endoscopic Submucosal Dissection (ESD) Devices, Biopsy Forceps, Clips And Closure Devices, Electrosurgical Devices
2) By Endoscopic Retrograde Cholangio Pancreatography (ERCP) Devices And Accessories: ERCP Cannulas, Balloon Sweep Devices, Stents, Guidewires, Sphincterotomes
3) By Other Endotherapy Devices: Endoscopic Ultrasound (EUS) Devices, Ablation Devices, Foreign Body Retrieval Devices, Laser Therapy Devices

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=10157&type=smp

Who Are the Key Players Shaping the Endotherapy Devices Market's Competitive Landscape?
Major companies operating in the endotherapy devices market include Olympus Corporation, Boston Scientific Corporation, Conmed Corporation, Medtronic Plc, Fujifilm Holdings Corporation, Johnson & JohnsonCook Group Incorporated, Karl Storz SE & Co. KG, Stryker Corporation, Taewoong Medical Co. Ltd, Smith & Nephew Plc., Steris Corporation, Micro-Tech (Nanjing) Co Ltd., HOYA Corporation, Cook Group Incorporated, B. Braun Melsungen AG, Frontier Healthcare, Pentax Medical, Nipro Corporation, MEDIVATORS B.V., US Endoscopy Group Inc., Richard Wolf GmbH, Cantel Medical Corp., Fujinon Corporation, Gyrus ACMI, Cogentix Medical Inc., Endogastric Solutions Inc.

What Geographic Markets Are Powering Growth in the Endotherapy Devices Market?
North America as the largest region in the endotherapy devices market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global endotherapy devices market report during the forecast period. The regions covered in the endotherapy devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10157

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.